PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Hammerschmidt, W. ; Sugden, B.*

Replication of Epstein-Barr viral DNA.

Cold Spring Harbor Perspect. Biol. 5:a013029 (2013)
Publ. Version/Full Text DOI PMC
Free by publisher
Epstein-Barr virus (EBV) is a paradigm for human tumor viruses: it is the first virus recognized to cause cancer in people; it causes both lymphomas and carcinomas; yet these tumors arise infrequently given that most people in the world are infected with the virus. EBV is maintained extrachromosomally in infected normal and tumor cells. Eighty-four percent of these viral plasmids replicate each S phase, are licensed, require a single viral protein for their synthesis, and can use two functionally distinct origins of DNA replication, oriP, and Raji ori. Eighty-eight percent of newly synthesized plasmids are segregated faithfully to the daughter cells. Infectious viral particles are not synthesized under these conditions of latent infection. This plasmid replication is consistent with survival of EBV's host cells. Rare cells in an infected population either spontaneously or following exogenous induction support EBV's lytic cycle, which is lethal for the cell. In this case, the viral DNA replicates 100-fold or more, uses a third kind of viral origin of DNA replication, oriLyt, and many viral proteins. Here we shall describe the three modes of EBV's replication as a function of the viral origins used and the viral and cellular proteins that mediate the DNA synthesis from these origins focusing, where practical, on recent advances in our understanding.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
9.630
0.000
58
69
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Origin Recognition Complex ; Ebv Nuclear Antigen-1 ; Polymerase Processivity Factor ; Virus Lytic Replication ; Latent Cycle Origin ; Binding Protein ; Transcriptional Activation ; Downstream Component ; Episomal Maintenance ; Catalytic Subunit
Language english
Publication Year 2013
HGF-reported in Year 2013
e-ISSN 1943-0264
Journal Cold Spring Harbor Perspectives in Biology
Quellenangaben Volume: 5, Issue: 1, Pages: , Article Number: a013029 Supplement: ,
Publisher Cold Spring Harbor Laboratory Press
Reviewing status Peer reviewed
Institute(s) Research Unit Gene Vector (AGV)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-501500-001
PubMed ID 23284049
DOI 10.1101/cshperspect.a013029
WOS ID WOS:000315983600012
Scopus ID 84872046551
Erfassungsdatum 2013-04-04
[➜Report correction]